Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALBOCICLIB vs RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALBOCICLIB vs RIBOCICLIB: Safety Overview

Metric PALBOCICLIB RIBOCICLIB
Total FAERS Reports 91,024 27,997
Deaths Reported 11,066 4,501
Death Rate 12.2% 16.1%
Hospitalizations 13,442 6,700
Average Patient Age 66.0 yrs 60.2 yrs
% Female Patients 97.7% 99.0%
FDA Approval Date Feb 3, 2015 Mar 13, 2017
Manufacturer Pfizer Laboratories Div Pfizer Inc Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription